Psychotic Illness Appears to Begin at Younger Age Among Those Who Use Cannabis – Cannabis use appears to be associated with an earlier onset of psychotic illness, according to a meta-analysis of previously published studies published in Archives of General Psychiatry.
Reducing diet early in pregnancy stunts fetal brain development — Study shows that the fetal brain is vulnerable to moderate decreases in maternal nutrition – Eating less during early pregnancy impaired fetal brain development in a nonhuman primate model, revealed by researchers from The University of Texas Health Science Center San Antonio.
First genetic link to common migraine exposed — Genetic variant may increase susceptibility to migraine triggers – Researchers have produced new insights into the triggers for migraines attacks. They have identified the first-ever genetic risk factor associated with common types of migraine.
Blood flows differently through the brains of schizophrenic patients – Researchers in Germany have used a magnetic resonance imaging (MRI) technique called continuous arterial spin labeling (CASL) to map cerebral blood flow patterns in schizophrenic patients quickly and without using radiation or contrast agents. Their findings appear in the online edition and July printed issue of the journal Radiology.
ATTENTION PARENTS AND TEACHERS! LEARN TO DEAL WITH INATTENTIVE, HYPERACTIVE & IMPULSIVE KIDS – ADHD is a disorder of the brain and behavior. It affects about 3 to 5% of children. The symptoms start before seven years of age. Global prevalence for children is approximately 5%, with wide variability dependent on research methodologies utilized in studies.
FDA grants approval for use of RISPERDAL CONSTA as both a monotherapy and adjunctive therapy in the maintenance treatment of Bipolar I Disorder – Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Applications (sNDAs) for the use of RISPERDAL? CONSTA? (risperidone) Long-Acting Treatment as both monotherapy and adjunctive therapy to lithium or valproate in the maintenance treatment of Bipolar I Disorder.
Children of older fathers perform less well in intelligence tests during infancy – Children of older fathers perform less well in a range of cognitive tests during infancy and early childhood, according to a study published this week in the open-access journal PLoS Medicine.
Functional abnormalities within a neural system subserves self-regulatory control, which may contribute to binge eating and other impulsive behaviors in women with Bulimia nervosa (BN). – Women with bulimia nervosa appear to respond more impulsively during psychological testing than those without eating disorders, and brain scans show differences in areas responsible for regulating behavior, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
AstraZeneca Receives FDA Complete Response Letter on Seroquel XR for Major Depressive Disorder – AstraZeneca announced the company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) asking for additional information for the supplemental New Drug Application for SEROQUEL XR (quetiapine fumarate) Extended Release Tablets for the treatment of Major Depressive Disorder (MDD) in adult patients.
Researchers have developed a list of 14 widely prescribed medications most urgently in need of additional study to determine how effective and safe they are for their off-label uses. – Physicians and policy-makers know that drugs are frequently prescribed to treat certain diseases despite a lack of FDA approval – a practice known as off-label prescribing. Yet they say the problem is so big they don’t know how to begin tackling it.
